Zobrazeno 1 - 6
of 6
pro vyhledávání: '"K. Gkialas"'
Autor:
E. Farsari, K.D. Pagonis, P. Ntasiotis, C. Adamou, A. Vagionis, G.A. Callas, K. Gkialas, A. Gerakaris, E. Liatsikos, P. Kallidonis
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e28-e29 (2020)
Externí odkaz:
https://doaj.org/article/3481c7abab18406380af63fb784c66d1
Autor:
C. Adamou, E. Farsari, P. Ntasiotis, A. Vagionis, A. Gerakaris, K. Gkialas, G. Callas, K. Pagonis, E. Liatsikos, P. Kallidonis
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp e30- (2020)
Externí odkaz:
https://doaj.org/article/aa123e195b6f4b5390251290017b8743
Autor:
Athanasios Vagionis, A. Gerakaris, G.A. Callas, E. Farsari, P. Ntasiotis, C. Adamou, P. Kallidonis, E. Liatsikos, Konstantinos Pagonis, K. Gkialas
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e28-e29 (2020)
Autor:
G.A. Callas, Konstantinos Pagonis, C. Adamou, E. Liatsikos, A. Gerakaris, Athanasios Vagionis, K. Gkialas, P. Ntasiotis, E. Farsari, P. Kallidonis
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e30-(2020)
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(6)
Building on decades of research, the past few years have yielded a near expo-nential increase in treatment modalities for patients with metastatic prostate cancer. Individually, these improvements in overall survival may appear modest, however, nearl
Autor:
I K, Gkialas, G, Papadopoulos
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 14(3)
Renal cell carcinoma (RCC) accounts for approximately 2% of all cancers worldwide. For several decades cytokine therapy using either interleukin-2 (IL-2) or interferon -alpha (IFN-alpha) was the only effective treatment available for patients with me